anurajms/meta_analysis huggingface dataset:
outcomes:
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Death 4. Lung function test 5. Infection due to Pseudomonas Aeruginosa
outcomes:
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Cystic Fibrosis Pulmonary Exacerbation 4. Quality of Life 5. Lung function test 6. Time-to-Event
outcomes:
Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease
1. Low Cardiac Output Syndrome 2. Death 3. Adverse Event
outcomes:
Surgical interventions for treating pectus excavatum
1. Exercise Tolerance Test 2. Disease Recurrence 3. Surgical complication
outcomes:
Sodium channel blockers for cystic fibrosis
1. All Cause Mortality 2. Respiratory exacerbation 3. Lung function test 4. Adverse Event 5. Survival
outcomes:
Vaccines for preventing influenza in people with cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity
outcomes:
Interventions for promoting physical activity in people with cystic fibrosis
1. Physical activity
outcomes:
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Pulmonary function
outcomes:
Single‐incision sling operations for urinary incontinence in women
1. Postoperative Complication 2. Urodynamic studies 3. Repair Of Urinary Stress Incontinence 4. Urinary Retention 5. Repeat surgery 6. Length Of Stay 7. Time-to-Event 8. Urge Incontinence 9. Patient-Reported Outcome 10. Dyspareunia 11. Returns To Baseline Activity Status 12. Intraoperative Complications 13. Erosion of Tape Into Vagina 14. Quality of Life 15. Procedure 16. Duration Of Hospital Stay 17. Urinary Incontinence 18. Reconstruction Of Pelvic Floor 19. Chronic Pain
outcomes:
Surgical approach to hysterectomy for benign gynaecological disease
1. Internal Injury 2. Quality of Life 3. Abdominal Pain 4. Functional ability
outcomes:
Combined oral contraceptive pill for primary dysmenorrhoea
1. Pain 2. Adverse Event
outcomes:
Surgery for women with apical vaginal prolapse
1. Repair Of Urinary Stress Incontinence 2. Pelvic Floor Distress Inventory 3. Repeat surgery 4. Uterine Prolapse 5. Stress urinary incontinence 6. Pelvic Organ Prolapse Quantification System 7. Accidental Bladder Perforation During Operation 8. Pelvic Organ Prolapse Urinary Incontinence Sexual Questionnaire 9. Patient-Reported Outcome 10. Dyspareunia 11. Disease Recurrence 12. Surgical Repair Of Prolapsed Uterus 13. Vaginal Vault Prolapse 14. Bulge Of Vagina
outcomes:
Statins for women with polycystic ovary syndrome not actively trying to conceive
1. Ovulation Present 2. Regular Periods
outcomes:
Gonadotropin‐releasing hormone analogues for endometriosis
1. Pain 2. Bone Density
outcomes:
Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults
1. Urinary urgency 2. Health-Related Quality of Life 3. Clinical Improvement
outcomes:
Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception
1. Adverse Drug Reaction 2. Plastic Iud 3. Normal Breast Feeding 4. Pregnancy 5. Unplanned Pregnancy 6. Abnormal Vaginal Bleeding 7. Initiation Of Contraception 8. Breastfeeding 9. Patient Satisfaction
outcomes:
Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency
1. Uterus volume
outcomes:
Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use
1. Pain 2. Finding Of Quantity Of Menstrual Blood Loss
outcomes:
Medical methods for first trimester abortion
1. Abortion Complete
outcomes:
Immediate versus delayed postabortal insertion of contraceptive implant
1. Side effects 2. Failed attempted abortion 3. Contraceptive implant
outcomes:
Treatment for recurrent vulvovaginal candidiasis (thrush)
1. Genitourinary Symptoms 2. Recurrent Candidiasis Of Vagina 3. Patient preference 4. Adverse Event
outcomes:
Surgical interventions for the management of chronic pelvic pain in women
1. Mcgill Pain Chart Questionnaire 2. Visual Analog Pain Scale 3. Surgical complication 4. Sickness Impact Profile 5. Sabbatsberg Sexual Rating Scale 6. Depression 7. Adverse Event 8. Social Adjustment Scale 9. Euroqol 10. Pain 11. Hospital Anxiety And Depression Scale 12. Short Form Health Survey - 36 13. Hamilton Rating Scale For Depression 14. Quality of Life 15. General Health Questionnaire
outcomes:
Levonorgestrel‐releasing intrauterine device (LNG‐IUD) for symptomatic endometriosis following surgery
1. Pain 2. Dysmenorrhea 3. Symptom recurrence
outcomes:
Ultrasound‐guided transvaginal ovarian needle drilling for clomiphene‐resistant polycystic ovarian syndrome in subfertile women
1. Surgical complication 2. Ovulation Present 3. Multiple Pregnancy 4. Live Birth 5. Pregnancy 6. Miscarriage 7. Ovarian Hyperstimulation Syndrome
outcomes:
Pentoxifylline for the treatment of endometriosis‐associated pain and infertility  
1. Pain 2. Live Birth 3. Endometriosis 4. Miscarriage 5. Clinical Pregnancy 6. Adverse Event
outcomes:
Medical abortion offered in pharmacy versus clinic‐based settings
1. Blood Transfusion 2. Uterine Infection 3. Systemic infection 4. Abortion
outcomes:
Selective oestrogen receptor modulators (SERMs) for endometriosis
1. Pelvic Pain 2. Adverse Event
outcomes:
Dopamine agonists for preventing ovarian hyperstimulation syndrome
1. Multiple Pregnancy 2. Live Birth 3. Miscarriage 4. Clinical Pregnancy 5. Severe Hyperstimulation Of Ovaries 6. Ovarian Hyperstimulation Syndrome
outcomes:
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
1. Live Birth 2. Clinical Pregnancy 3. Ovarian Hyperstimulation Syndrome
outcomes:
Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
1. Menopausal Symptom 2. Bleeding Between Periods 3. Abnormal Uterine Bleeding 4. Uterine fibroid size
outcomes:
Pessaries (mechanical devices) for managing pelvic organ prolapse in women
1. Pelvic prolapse 2. Quality of Life 3. Pelvic Floor Disability Index 4. Adverse Event
outcomes:
Pre‐ and postsurgical medical therapy for endometriosis surgery
1. Disease Recurrence 2. Pregnancy 3. Chronic Pelvic Pain Of Female 4. Symptom recurrence
outcomes:
Laparoscopic surgery for endometriosis
1. Quality Of Life Scale 2. Live Birth 3. Quality of Life 4. Ectopic Pregnancy 5. Intrauterine Pregnancy 6. Laparotomy 7. Adverse Event 8. Pain Relief
outcomes:
Surgical treatment for tubal disease in women due to undergo in vitro fertilisation
1. Live Birth 2. Pelvic Infection 3. Ectopic Pregnancy 4. Miscarriage 5. Clinical Pregnancy 6. Laparotomy 7. Wound Infection
outcomes:
Tubal flushing for subfertility
1. Ongoing Pregnancy 2. Live Birth 3. Adverse Event
outcomes:
Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia
1. Device Withdrawn And / Or Removed 2. Healthcare costs 3. Endometrial Hyperplasia 4. Vaginal Bleeding 5. Nausea 6. Hysterectomy 7. Weight Gain 8. Adverse Event 9. Patient Satisfaction
outcomes:
Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
1. Duration of Symptom 2. Adverse Drug Reaction 3. Costs and Cost Analysis 4. Mycological Cure 5. Clinical Cure 6. Withdrawal Due To Adverse Events 7. Patient Satisfaction 8. Patient-Reported Outcome
outcomes:
Interventions for non‐tubal ectopic pregnancy
1. Maternal Blood Loss Heavy 2. Human Chorionic Gonadotropin Level 3. Treatment Success 4. Complication
outcomes:
Progestogen‐releasing intrauterine systems for heavy menstrual bleeding
1. Treatment Withdrawal 2. Costs and Cost Analysis 3. Serious Adverse Event 4. Treatment Failure 5. Finding Of Quantity Of Menstrual Blood Loss 6. Quality of Life 7. Parent satisfaction
outcomes:
In‐bag manual versus uncontained power morcellation for laparoscopic myomectomy
1. Postoperative Complication 2. Injury To Viscus During Surgery 3. Visual Analog Pain Scale 4. Postoperative Pain 5. Length of Procedure 6. Leiomyosarcoma 7. Length Of Stay 8. Ease of use 9. Injury To Liver During Surgery 10. Laparotomy
outcomes:
Self‐administered versus provider‐administered medical abortion
1. Abortion Complete
outcomes:
Traditional suburethral sling operations for urinary incontinence in women
1. Postoperative Complication 2. Repair Of Urinary Stress Incontinence 3. Repeat surgery 4. Length Of Stay 5. Accidental Bladder Perforation During Operation 6. Time-to-Event 7. Urge Incontinence 8. Dysfunctional Voiding Of Urine 9. Clinical Improvement 10. Patient-Reported Outcome 11. Returns To Baseline Activity Status 12. Intraoperative Complications 13. Treatment Success 14. Quality of Life 15. Duration Of Hospital Stay 16. Urinary Incontinence 17. Reconstruction Of Pelvic Floor
outcomes:
Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
1. Ovulation Assessment 2. Gastrointestinal findings 3. Live Birth 4. Clinical Pregnancy 5. Miscarriage
outcomes:
Laparoscopic colposuspension for urinary incontinence in women
1. Postoperative Complication 2. Urodynamic studies 3. Repair Of Urinary Stress Incontinence 4. Repeat surgery 5. Urinary urgency 6. Length Of Stay 7. Time-to-Event 8. Dysfunctional Voiding Of Urine 9. Urinary Frequency Volume Chart 10. Patient-Reported Outcome 11. Postoperative Pain 12. Returns To Baseline Activity Status 13. Intraoperative Complications 14. Treatment Success 15. Quality of Life 16. Duration Of Hospital Stay 17. Urinary Incontinence
outcomes:
Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
1. Number of Oocytes Aspirated 2. Multiple Pregnancy 3. Live Birth 4. Complication 5. Miscarriage 6. Clinical Pregnancy 7. Number of Embryos
outcomes:
Exercise for dysmenorrhoea
1. Analgesics 2. Assessment Of Quality Of Life 3. Fatigue 4. Nausea 5. Absenteeism 6. Adverse Event 7. Back pain 8. Dysmenorrhea 9. Activities Of Daily Living Assessment
outcomes:
Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding
1. Finding Of Menstrual Bleeding 2. Quality of Life 3. Finding Of Quantity Of Menstrual Blood Loss
outcomes:
Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women
1. Urodynamic studies 2. Repeat surgery 3. Treatment Success 4. Clinical Resolution 5. Stress urinary incontinence 6. Health Status 7. Adverse Event 8. Clinical Improvement 9. Patient-Reported Outcome
outcomes:
Cyclical progestogens for heavy menstrual bleeding
1. Headache 2. Finding Of Menstrual Bleeding 3. Duration of Symptom 4. Break-through Bleeding 5. Finding Of Quantity Of Menstrual Blood Loss 6. Quality of Life 7. Adverse Event 8. Functional ability 9. Patient Satisfaction
outcomes:
Antibiotic therapy for adults with neurosyphilis
1. Quality of Life 2. Clinical Cure 3. Adverse Event 4. Neurosyphilis
outcomes:
Robot‐assisted surgery in gynaecology
1. Postoperative Complication 2. Blood Transfusion 3. Surgical complication 4. Surgery 5. Duration Of Surgery 6. Duration Of Hospital Stay
outcomes:
Lifestyle changes in women with polycystic ovary syndrome
1. Body Mass Index 2. Fasting plasma glucose 3. Live Birth 4. Body weight 5. Pregnancy 6. Androgen Level 7. Miscarriage
outcomes:
Combined hormonal contraceptives for heavy menstrual bleeding
1. Evaluating Response To Treatment 2. Finding Of Quantity Of Menstrual Blood Loss 3. Nausea 4. Patient Satisfaction
outcomes:
Interventions to reduce shoulder pain following gynaecological laparoscopic procedures
1. Analgesics 2. Shoulder Pain From Abdomen
outcomes:
Endometrial resection and ablation techniques for heavy menstrual bleeding
1. Local Anesthesia 2. Duration Of Surgery 3. Finding Of Quantity Of Menstrual Blood Loss 4. Complication 5. General Anesthetics 6. Patient Satisfaction
outcomes:
Gonadotrophins for ovulation induction in women with polycystic ovary syndrome
1. Multiple Pregnancy 2. Live Birth 3. Miscarriage 4. Clinical Pregnancy 5. Ovarian Hyperstimulation Syndrome
outcomes:
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
1. Urinary Continence 2. International Consultation On Incontinence Questionnaire Short Form 3. Pad Test For Incontinence 4. Quality of Life 5. Urinary Incontinence 6. Functional ability 7. Clinical Improvement 8. Urinary Frequency Volume Chart 9. Patient-Reported Outcome
outcomes:
Surgery for women with pelvic organ prolapse with or without stress urinary incontinence
1. Disease Recurrence 2. Repair Of Urinary Stress Incontinence 3. Repeat surgery 4. Treatment Success 5. Genital prolapse 6. Overactive Bladder Syndrome 7. Stress urinary incontinence 8. Pelvic Organ Prolapse Quantification System 9. Dysfunctional Voiding Of Urine 10. Clinical Improvement 11. Patient-Reported Outcome
outcomes:
Acupuncture and acupressure for premenstrual syndrome
1. Quality of Life 2. Withdrawal Due To Adverse Events 3. Premenstrual Symptom 4. Adverse Event 5. Therapeutic Response
outcomes:
Oral contraceptives for pain associated with endometriosis
1. Dysmenorrhea
outcomes:
Surgery for women with posterior compartment prolapse
1. Surgical complication 2. Repeat surgery 3. Repair Of Vaginal Wall Prolapse 4. Genital prolapse 5. Clinician-Reported Outcome 6. Posterior Repair Of Vagina 7. Patient-Reported Outcome 8. Dyspareunia 9. Length of Procedure 10. Posterior Vaginal Wall Prolapse 11. Disease Recurrence 12. Obstructive Defecation Syndrome 13. Bulge Of Vagina
outcomes:
Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
1. Finding Of Frequency Of Menstruation 2. Ovulation Present 3. Gastrointestinal findings 4. Live Birth 5. Clinical Pregnancy 6. Miscarriage
outcomes:
Preoperative medical therapy before surgery for uterine fibroids
1. Length of Procedure 2. Blood Transfusion 3. Postoperative Morbidity 4. Intraoperative Hemorrhage Requiring Transfusion 5. Abnormal Uterine Bleeding 6. Uterus size 7. Hemoglobin concentration
outcomes:
Anterior vaginal repair for urinary incontinence in women
1. Postoperative Hemorrhage 2. Postoperative Complication 3. Difficulty In Micturition 4. Repeat surgery 5. Urinary urgency 6. Genital prolapse 7. Stress urinary incontinence 8. Hospitalization 9. Postoperative Urinary Tract Infection 10. Accidental Bladder Perforation During Operation 11. Urine Culture Positive 12. Chronic Postoperative Pain 13. Urge Incontinence 14. Dysfunctional Voiding Of Urine 15. Dyspareunia 16. Intraoperative Complications 17. Quality of Life 18. Death 19. Urethral Catheterization 20. Postoperative Fever
outcomes:
Mid‐urethral sling operations for stress urinary incontinence in women
1. Repair Of Urinary Stress Incontinence 2. Suprapubic Pain 3. Repeat surgery 4. Urinary urgency 5. Accidental Bladder Perforation During Operation 6. Dysfunctional Voiding Of Urine 7. Urge Incontinence 8. Clinical Improvement 9. Patient-Reported Outcome 10. Erosion of Tape Into Vagina 11. Treatment Success 12. Quality of Life 13. Inguinal Pain 14. Urinary Incontinence
outcomes:
Open retropubic colposuspension for urinary incontinence in women
1. Postoperative Complication 2. Intraoperative Complications 3. Repair Of Urinary Stress Incontinence 4. Repeat surgery 5. Quality of Life 6. Genital prolapse 7. Complication 8. Accidental Bladder Perforation During Operation 9. Urinary Incontinence 10. Urge Incontinence 11. Dysfunctional Voiding Of Urine 12. Patient-Reported Outcome
outcomes:
Bladder neck needle suspension for urinary incontinence in women
1. Urinary Pad Weighing 2. Urodynamic studies 3. Surgical complication 4. Repeat surgery 5. Overactive Bladder Syndrome 6. Length Of Stay 7. Genital prolapse 8. Stress urinary incontinence 9. Needle Suspension Procedure Of Bladder Neck 10. Time-to-Event 11. Dysfunctional Voiding Of Urine 12. Urinary Frequency Volume Chart 13. Patient-Reported Outcome 14. Dyspareunia 15. Returns To Baseline Activity Status 16. Disease Recurrence 17. Death 18. Duration Of Hospital Stay 19. Urinary Incontinence 20. Incontinence Pants Liner 21. Reconstruction Of Pelvic Floor
outcomes:
Progesterone receptor modulators for endometriosis
1. Finding Of Menstrual Bleeding 2. Endometrial Hyperplasia 3. Pain Scale 4. Acne 5. Loss Of Appetite 6. Hirsutism 7. Hypoadrenalism 8. Fatigue 9. Nausea 10. Hot flush 11. Dyspareunia 12. Pain 13. Vomiting 14. Weight Loss 15. Atrophy Of Breast 16. Menstrual Spotting 17. Amenorrhea 18. Pelvic Pain 19. Skin Rash 20. Dysmenorrhea
outcomes:
Antibiotic prophylaxis for elective hysterectomy
1. Infection 2. Abdominal Infection 3. Pelvic Infection 4. Urinary Tract Infection 5. Adverse Event 6. Postoperative Fever
outcomes:
Selective progesterone receptor modulators (SPRMs) for uterine fibroids
1. Endometrial Cancer 2. Endometrial Hyperplasia 3. Quality of Life 4. Amenorrhea 5. Abnormal Uterine Bleeding 6. Pelvic Pain
outcomes:
Washout policies in long‐term indwelling urinary catheterisation in adults
1. Urinary Catheter In Situ 2. Removal Of Urinary Catheter 3. Number of Urinary Catheters 4. Urinary Tract Infection Associated With Catheter 5. Time-to-Event 6. Asymptomatic Bacteriuria
outcomes:
Surgery for tubal infertility
1. Multiple Pregnancy 2. Live Birth 3. Ectopic Pregnancy 4. Clinical Pregnancy 5. Ovarian Hyperstimulation Syndrome
outcomes:
Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis
1. Activities of Daily Living 2. Adverse Drug Reaction 3. Employee absenteeism 4. Pain 5. Assessment Of Quality Of Life 6. Surgery 7. Rescue Medication 8. Pain Relief 9. Patient Satisfaction
outcomes:
Long‐term hormone therapy for perimenopausal and postmenopausal women
1. Cognitive function 2. Death 3. Adverse Event
outcomes:
Surgery for women with anterior compartment prolapse
1. Anterior Colporrhaphy 2. Dyspareunia 3. Disease Recurrence 4. Anterior Vaginal Wall Prolapse 5. Repair Of Urinary Stress Incontinence 6. Removal Of Mesh From Wound 7. Pelvic Floor Distress Inventory 8. Repeat surgery 9. Stress urinary incontinence 10. Clinician-Reported Outcome 11. Bulge Of Vagina 12. Patient-Reported Outcome
outcomes:
Interventions for preventing and treating incontinence‐associated dermatitis in adults
1. Pain 2. Allergic Reaction 3. Disease Recurrence 4. Adverse Reaction 5. Irritant Contact Dermatitis Due To Incontinence 6. Patient-Reported Outcome
outcomes:
Short‐term and long‐term effects of tibolone in postmenopausal women
1. Endometrial Cancer 2. Menopausal Symptom 3. All Cause Mortality 4. Cardiovascular Event 5. Cerebrovascular Events 6. Abnormal Uterine Bleeding 7. Thromboembolic Event 8. Breast Cancer
outcomes:
Antibiotic treatment for the sexual partners of women with bacterial vaginosis
1. Disease Recurrence 2. Adverse Event 3. Clinical Improvement
outcomes:
Techniques for the interruption of tubal patency for female sterilisation
1. Infection 2. Postoperative Complication 3. Intraoperative Complications 4. Pain 5. Blood Transfusion 6. Revision 7. Injury To Blood Vessel During Surgery 8. Unplanned Pregnancy 9. Injury Of Pelvic Organs 10. Ectopic Pregnancy 11. Readmission 12. Intraoperative Death
outcomes:
Bioidentical hormones for women with vasomotor symptoms
1. Quality of Life 2. Hot flush
outcomes:
Policies for replacing long‐term indwelling urinary catheters in adults
1. Injury Of Urinary Tract 2. Quality of Life 3. Urinary Tract Infection 4. Death 5. Patient-Reported Outcome
outcomes:
Antibiotics for treating septic abortion
1. Single organ failure 2. Microbial Culture Finding 3. Vaginal Discharge 4. Inflammation 5. Hospitalization 6. Maternal Death 7. Fever 8. Tubo-ovarian Abscess 9. Clinical Improvement 10. Remittent Fever 11. Adverse Drug Reaction 12. Quality of Life 13. Death 14. Pelvic Pain 15. Sample Clear
outcomes:
Chinese herbal medicine for menopausal symptoms
1. Menopausal Symptom 2. Night Sweats 3. Quality of Life 4. Hot flush 5. Patient Satisfaction
outcomes:
Tricyclic and related drugs for nocturnal enuresis in children
1. Disease Recurrence 2. Non-organic Primary Nocturnal Enuresis 3. Non-organic Nocturnal Enuresis 4. Urinary Frequency Volume Chart
outcomes:
Trocar types in laparoscopy
1. Incision site complication 2. Postoperative Pain 3. Internal Injury Of Pelvic Organs 4. Vascular Injury
outcomes:
Urethral (indwelling or intermittent) or suprapubic routes for short‐term catheterisation in hospitalised adults
1. Pain 2. Euroqol Five Dimension Questionnaire 3. Quality of Life 4. Urinary Tract Infection 5. Asymptomatic Bacteriuria 6. Patient-Reported Outcome
outcomes:
Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women
1. Short Form Health Survey - 36 2. Treatment Success 3. Surgery 4. Pad Test For Incontinence 5. Drug Therapy 6. Quality of Life 7. Non-Surgical Interventions 8. Patient Global Impression of Improvement 9. Urinary Incontinence 10. Clinical Improvement 11. Patient-Reported Outcome
outcomes:
Hormonal and intrauterine methods for contraception for women aged 25 years and younger
1. Pregnancy
outcomes:
Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea
1. Adverse Event 2. Pain Relief
outcomes:
Interventions for pain with intrauterine device insertion
1. Postoperative Pain 2. Uterine Tenaculum 3. Insertion Of Hormone Releasing Intrauterine Contraceptive Device 4. Intraoperative Pain 5. Patient Satisfaction
outcomes:
Doctors or mid‐level providers for abortion
1. Traumatic Injury 2. Incomplete Miscarriage 3. Hematometra 4. Intestinal Perforation 5. Complication Of Anesthesia 6. Hospitalization 7. Perforation Of Uterus 8. Hemorrhage 9. Whole Blood Transfusion
outcomes:
Immediate postpartum insertion of intrauterine device for contraception
1. Infection 2. Retained Intrauterine Contraceptive Device 3. Pregnancy 4. Expulsion Intrauterine Contraceptive Device
outcomes:
Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction
1. Disease Recurrence 2. Repeat surgery 3. Surgery 4. Quality of Life 5. Urinary Tract Infection 6. Procedure 7. Dysfunctional Voiding Of Urine 8. Patient Satisfaction 9. Patient-Reported Outcome
outcomes:
Preoperative ripening of the cervix before operative hysteroscopy
1. Intraoperative Hemorrhage 2. Intraoperative Complications 3. Cervical false passage 4. Failure Of Cervical Dilation 5. Perforation Of Uterus 6. Cervical Laceration
outcomes:
Add‐back therapy with GnRH analogues for uterine fibroids
1. Bone Density 2. Quality of Life 3. Abnormal Uterine Bleeding 4. Uterus size 5. Abnormal Vasomotor Function
outcomes:
Transurethral radiofrequency collagen denaturation for the treatment of women with urinary incontinence
1. Intraoperative Complications 2. Repair Of Urinary Stress Incontinence 3. Repeat surgery 4. Quality of Life 5. Overactive Bladder Syndrome 6. Urinary Tract Infection 7. Urinary Incontinence 8. Dysuria 9. Patient-Reported Outcome
outcomes:
Hormone therapy for preventing cardiovascular disease in post‐menopausal women
1. Myocardial Infarction 2. Stroke 3. Angina Pectoris 4. Venous Thrombosis 5. Death 6. Pulmonary Embolism 7. Coronary Revascularisation
outcomes:
Nitric oxide donors for cervical ripening in first‐trimester surgical abortion
1. Infection 2. Adverse Drug Reaction 3. Intraoperative Complications 4. Blood Transfusion 5. Injury Of Cervix 6. Cervical Dilatation Finding 7. Perforation Of Uterus 8. Maternal Death 9. Patient Satisfaction
outcomes:
Conservative management for postprostatectomy urinary incontinence
1. International Consultation On Incontinence Questionnaire Short Form 2. Adverse Reaction 3. Quality of Life 4. Urinary Incontinence 5. Patient-Reported Outcome
outcomes:
Imiquimod for anogenital warts in non‐immunocompromised adults
1. Dyspareunia 2. Adverse Drug Reaction 3. Pain 4. Disease Recurrence 5. Treatment Failure 6. Anogenital Warts
outcomes:
Minimally invasive surgical techniques versus open myomectomy for uterine fibroids
1. Postoperative Pain 2. Adverse Event 3. Postoperative Fever
outcomes:
Types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults
1. Urosepsis 2. Urinary Tract Infection Associated With Catheter
outcomes:
Non‐surgical interventions for the management of chronic pelvic pain
1. Pain 2. Dry Mouth 3. Lethargy 4. Weight Gain 5. Sleepiness 6. Abdominal Bloating
outcomes:
Pre‐operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding
1. Surgery 2. Amenorrhea 3. Complication
outcomes:
Aromatase inhibitors for uterine fibroids
1. Finding Of Quantity Of Menstrual Blood Loss 2. Dysmenorrhea
outcomes:
Paracervical local anaesthesia for cervical dilatation and uterine intervention
1. Dilation Of Cervical Canal 2. Postoperative Pain 3. Analgesia 4. Pain 5. Sweating 6. Vomiting 7. Severe Pain 8. Low Blood Pressure 9. Nausea 10. Adverse Event
outcomes:
Prophylactic antibiotics for transcervical intrauterine procedures
1. Antibacterials For Systemic Use 2. Surgery 3. Postoperative Infection 4. Hospitalization 5. Postoperative Fever
outcomes:
Anti‐TNF‐α treatment for pelvic pain associated with endometriosis
1. Adverse Event 2. Pain Relief
outcomes:
Adapting shift work schedules for sleep quality, sleep duration, and sleepiness in shift workers
1. Quality Of Sleep 2. Sleepiness 3. Sleep duration
outcomes:
Splinting for carpal tunnel syndrome
1. Referral To Surgeon 2. Adverse Event 3. Carpal Tunnel Syndrome 4. Health-Related Quality of Life
outcomes:
Collective leadership to improve professional practice, healthcare outcomes and staff well‐being
1. Healthcare delivery 2. General well-being 3. Professional conduct
outcomes:
Pre‐deployment programmes for building resilience in military and frontline emergency service personnel
1. Posttraumatic Stress Disorder 2. Resilience
outcomes:
Exercise therapy for chronic low back pain
1. Pain 2. Functional ability
outcomes:
Interventions to improve return to work in depressed people
1. Psychotherapy 2. Depression 3. Assessment Using Work Ability Index 4. Sick Leave 5. Social functioning
outcomes:
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff
1. Severe Acute Respiratory Syndrome 2. Head 3. Compliance with safety precautions 4. Contamination 5. CDC doffing procedure 6. Ebola Virus Disease 7. Personal Protective Equipment 8. Infectious Diseases 9. MS2 10. Mask
outcomes:
Workplace interventions for increasing standing or walking for decreasing musculoskeletal symptoms in sedentary workers
1. Disability 2. Upper Backache 3. Low back pain 4. Musculoskeletal System 5. Shoulder Pain 6. Neck Pain
outcomes:
Work‐break schedules for preventing musculoskeletal symptoms and disorders in healthy workers
1. Professional performance 2. Musculoskeletal discomfort 3. Musculoskeletal Pain 4. Musculoskeletal fatigue 5. Patient-Reported Outcome
outcomes:
Incentives for smoking cessation
1. Smoking cessation
outcomes:
Ergonomic interventions for preventing work‐related musculoskeletal disorders of the upper limb and neck among office workers
1. Shoulder disorder 2. Pain In Left Arm 3. Returns To Baseline Activity Status 4. Discomfort 5. Disorder Of Neck 6. Pain In Right Arm 7. Musculoskeletal Pain 8. Hand Pain 9. Disorder Of Upper Extremity
outcomes:
Ergonomic interventions for preventing musculoskeletal disorders in dental care practitioners
1. Thigh Pain 2. Work-related musculoskeletal disorders 3. Work productivity 4. Musculoskeletal Disorder 5. Nordic Musculoskeletal Questionnaire 6. Job change 7. Unemployment 8. Foot Pain 9. Patient-Reported Outcome 10. Disability 11. Professional performance 12. Working hours 13. Work-related disability 14. Lost workdays
outcomes:
Closed‐system drug‐transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff
1. Environmental contamination 2. Costs and Cost Analysis 3. Surface contamination 4. Contamination 5. Infertility 6. Clinical Outcome 7. Environmental Exposure 8. Miscarriage 9. Adverse Event 10. Cancer
outcomes:
Workplace lighting for improving alertness and mood in daytime workers
1. Mental Alertness 2. Visual discomfort 3. Positive And Negative Affect Scale 4. Mood 5. Functional Vision Problem
outcomes:
Multidisciplinary biopsychosocial rehabilitation for subacute low back pain
1. Disability 2. Pain 3. Low back pain 4. Sick Leave 5. Return to Work 6. Adverse Event
outcomes:
Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions
1. Lower Respiratory Tract Infection 2. Influenza 3. Death 4. Hospitalization 5. Elderly
outcomes:
Rehabilitation following carpal tunnel release
1. Grip Strength
outcomes:
Organisational interventions for improving wellbeing and reducing work‐related stress in teachers
1. Occupational stress 2. Staff turnover 3. Cardiovascular observations 4. Sick Leave 5. Maslach Burnout Inventory
outcomes:
Exercises for mechanical neck disorders
1. Disability 2. Costs and Cost Analysis 3. Pain 4. Pain Scale 5. Quality of Life 6. Patient Global Impression of Improvement 7. Functional ability 8. Adverse Event 9. Patient Satisfaction 10. Pain Intensity
outcomes:
Multidisciplinary biopsychosocial rehabilitation for chronic low back pain
1. Disability 2. Pain 3. Sick Leave 4. Functional ability 5. Return to Work
outcomes:
Interventions for preventing the spread of infestation in close contacts of people with scabies
1. Scabies
outcomes:
Non‐pharmacological interventions for preventing venous insufficiency in a standing worker population
1. Venous insufficiency
outcomes:
Supported employment for adults with severe mental illness
1. Employment
outcomes:
Physical conditioning as part of a return to work strategy to reduce sickness absence for workers with back pain
1. Activity Alteration 2. Return to Work 3. Time-to-Event
outcomes:
Therapeutic ultrasound for carpal tunnel syndrome
1. Grip Strength 2. Paresthesia 3. Clinical Improvement
outcomes:
Training healthcare providers to respond to intimate partner violence against women
1. Health Knowledge Measurement 2. Counseling For Domestic Abuse 3. Attitude 4. Negative Attitude 5. Readiness Finding 6. Referral To Domestic Abuse Agency
outcomes:
Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation
1. Depression 2. Anxiety 3. Adverse Event 4. Health-Related Quality of Life
outcomes:
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease
1. Stroke 2. Coronary Heart Disease 3. Death 4. Medication adherence 5. Myocardial Revascularization
outcomes:
Prophylactic corticosteroids for cardiopulmonary bypass in adult cardiac surgery
1. Postoperative pulmonary complication 2. Cardiac Complication 3. Death
outcomes:
Exercise‐based cardiac rehabilitation for adults with heart failure
1. All Cause Mortality 2. Costs and Cost Analysis 3. Hospital admission 4. Heart Failure 5. Cardiovascular Mortality 6. Health-Related Quality of Life
outcomes:
Home‐based versus centre‐based cardiac rehabilitation
1. Treatment Withdrawal 2. Costs and Cost Analysis 3. Exercise Test Finding 4. Heart disease 5. Compliant Behavior 6. Death 7. At Risk
outcomes:
Effects of interventions targeting the systemic inflammatory response to cardiac surgery on clinical outcomes in adults
1. Clinical effectiveness 2. Efficacy
outcomes:
Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage
1. Dependence 2. Death
outcomes:
Cerebrolysin for acute ischaemic stroke
1. All Cause Mortality 2. Serious Adverse Event 3. Adverse Event
outcomes:
Pravastatin for lowering lipids
1. Adverse Reaction 2. Low Density Lipoprotein Cholesterol Measurement
outcomes:
First‐line diuretics versus other classes of antihypertensive drugs for hypertension
1. Stroke 2. Congestive Heart Failure 3. Serious Adverse Event 4. Cardiovascular Event 5. Aneurysm ruptured 6. Death 7. Hospitalization 8. Adverse Event
outcomes:
Physical exercise for the treatment of non‐ulcerated chronic venous insufficiency
1. Left Ventricular Ejection Fraction 2. Venous leg ulcer 3. Intensity of signs and symptoms
outcomes:
Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
1. Arterial Thrombosis 2. Venous Thrombosis
outcomes:
Family presence during resuscitation
1. Posttraumatic Stress Disorder
outcomes:
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
1. Venous Thrombosis 2. Pulmonary Embolism
outcomes:
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
1. All Cause Mortality 2. Pulmonary Embolism 3. Health-Related Quality of Life 4. Major Bleed 5. Deep Venous Thrombosis
outcomes:
General versus loco‐regional anesthesia for endovascular aortic aneurysm repair
1. All Cause Mortality 2. Length of ICU Stay 3. Length Of Stay
outcomes:
Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation
1. Atrial Arrhythmia 2. Adverse Event
outcomes:
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis
1. Blood Transfusion
outcomes:
Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis
1. Coronary artery restenosis 2. Ipsilateral stroke 3. Stroke 4. Death 5. Periprocedural period 6. Health-Related Quality of Life
outcomes:
Antithrombotic treatment after stroke due to intracerebral haemorrhage
1. Intracerebral Hemorrhage 2. Cognitive function 3. Myocardial Infarction 4. Extracranial haemorrhage 5. Ischemic Stroke 6. Death 7. Functional ability 8. Deep Venous Thrombosis
outcomes:
Intravenous immunoglobulin for the treatment of Kawasaki disease
1. Coronary Artery Abnormalities 2. Adverse Event
outcomes:
Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures
1. Death
outcomes:
Totally percutaneous versus surgical cut‐down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair
1. Operation time 2. Duration Of Surgery 3. Aneurysm 4. Death 5. Complication 6. Wound Infection
outcomes:
Peroxisome proliferator‐activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
1. Edema 2. Stroke 3. Anemia 4. Cardiovascular Mortality 5. Adverse Event
outcomes:
Balneotherapy for chronic venous insufficiency
1. Edema 2. Leg Ulcer 3. Pain 4. Euroqol Five Dimension Questionnaire 5. Skin Pigmentation 6. Adverse Event 7. Health-Related Quality of Life 8. Symptom severity
outcomes:
High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass
1. All Cause Mortality 2. Acute Nontraumatic Kidney Injury 3. Cognitive impairment
outcomes:
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
1. Venous Thrombosis 2. Major Bleed
outcomes:
Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding
1. Blood Component Transfusion 2. All Cause Mortality 3. Thrombotic event
outcomes:
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
1. Stroke 2. Congestive Heart Failure 3. Cardiovascular Event 4. Sudden Death 5. Cardiovascular Mortality 6. Adverse Event 7. Ruptured cerebral aneurysm 8. Withdrawn From Research Study 9. Myocardial Infarction 10. All Cause Mortality 11. Serious Adverse Event 12. Blood Pressure Alteration 13. Antihypertensive agents
outcomes:
Pharmaceutical interventions for emotionalism after stroke
1. Tearfulness 2. Center for Neurological Study-Lability Scale 3. Depression 4. Showing Emotion 5. Daily living activities 6. Clinical Interview-Based Impression
outcomes:
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
1. Persistent Vegetative State 2. All Cause Mortality 3. Disability - Severe 4. Death
outcomes:
Interventions for perceptual disorders following stroke
1. Activities of Daily Living 2. Functional ability 3. Psychological well-being
outcomes:
Endovascular therapy versus medical treatment for spontaneous isolated dissection of the superior mesenteric artery
1. Endovascular surgery 2. Abdominal Pain
outcomes:
Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism
1. All Cause Mortality 2. Morbidity
outcomes:
Action observation for upper limb rehabilitation after stroke
1. Activities of Daily Living 2. Motor Function Behavior Finding 3. Quality of Life 4. Adverse Event
outcomes:
Patch angioplasty versus primary closure for carotid endarterectomy
1. Stroke 2. Complication 3. Death 4. Cerebral artery restenosis 5. Arterial occlusion
outcomes:
Antiplatelet agents for the treatment of deep venous thrombosis
1. Pulmonary Embolism 2. Recurrent Deep Vein Thrombosis 3. Haemorrhage 4. Deep Venous Thrombosis
outcomes:
Type of anaesthesia for acute ischaemic stroke endovascular treatment
1. National Institutes Of Health Stroke Scale 2. Artery revascularisation 3. Neurological Impairment 4. Modified Rankin Scale 5. Death 6. Intracranial Hemorrhage 7. Adverse Event 8. Functional ability
outcomes:
Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults
1. Central Venous Catheter Occlusion 2. Catheter Sepsis 3. Death 4. Heparin-induced Thrombocytopenia 5. Hemorrhage
outcomes:
Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia
1. All Cause Mortality 2. Pain 3. Amputation
outcomes:
Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of monitoring in selective shunting)
1. Cognitive function 2. Stroke 3. Death
outcomes:
Corticosteroids for the treatment of Kawasaki disease in children
1. Serious Adverse Event 2. Coronary artery abnormality
outcomes:
Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis
1. Stroke 2. All Cause Mortality
outcomes:
Outpatient versus inpatient treatment for acute pulmonary embolism
1. All Cause Mortality 2. Recurrent Pulmonary Embolism 3. Minor Bleed 4. Major Bleed
outcomes:
Endovascular versus conventional open surgical repair for thoracoabdominal aortic aneurysms
1. Ischemic Disorder Of Spinal Cord 2. All Cause Mortality 3. Death 4. Ruptured Aneurysm Of Artery
outcomes:
Occupational therapy for cognitive impairment in stroke patients
1. Cognitive function 2. Basic Activity Of Daily Living 3. Finding Related To Orientation 4. Community integration 5. Instrumental Activities Of Daily Living Assessment 6. Attention 7. Functional ability
outcomes:
Angioplasty versus stenting for subclavian artery stenosis
1. Venous Patency 2. Blood Pressure 3. Quality of Life 4. Death 5. Reocclusion 6. Stent 7. Morbidity 8. Post angioplasty restenosis 9. Failure 10. Perioperative complication 11. Symptom control therapy
outcomes:
Ultrafiltration for acute heart failure
1. All Cause Mortality 2. Hospitalization
outcomes:
Oral antiplatelet therapy for acute ischaemic stroke
1. Disability 2. Death 3. Activities Of Daily Living Assessment
outcomes:
Calcium channel blockers versus other classes of drugs for hypertension
1. All Cause Mortality 2. Stroke 3. Myocardial Infarction 4. Systolic Blood Pressure 5. Congestive Heart Failure 6. Cardiovascular Event 7. Diastolic Blood Pressure 8. Cardiovascular Mortality
outcomes:
Percutaneous thrombectomy or ultrasound‐accelerated thrombolysis for initial management of acute limb ischaemia
1. Amputation 2. Primary Patency 3. Major Bleed
outcomes:
Propionyl‐L‐carnitine for intermittent claudication
1. Disease severity 2. Side effects 3. Disease Progression 4. Quality of Life 5. Walking Distance 6. Absolute claudication distance
outcomes:
Psychological and pharmacological interventions for depression in patients with coronary artery disease
1. Coronary artery bypass surgery 2. Myocardial Infarction 3. Stroke 4. Cardiac Arrhythmia 5. Angioplasty 6. Angina Pectoris 7. Heart Failure 8. Depression 9. Death 10. Coronary Revascularisation 11. Percutaneous Coronary Intervention
outcomes:
Endovascular versus open surgical repair for complicated chronic Type B aortic dissection
1. Visceral Ischemia 2. Stroke 3. Limb Ischemia 4. Acute Renal Failure 5. Death 6. Paralysis 7. Spinal cord ischaemia 8. Vertebrobasilar insufficiency 9. Health-Related Quality of Life
outcomes:
Injection sclerotherapy for varicose veins
1. Aching Pain 2. Cosmetic appearance 3. Sensation Of Heaviness In Limbs 4. Leg Oedema 5. Recurrent Disease 6. Burning Sensation 7. Thromboembolic Event 8. Itching 9. Nocturnal Muscle Cramp 10. Anaphylaxis 11. Pain 12. Superficial Thrombophlebitis 13. Skin Pigmentation 14. Hematoma 15. Quality of Life 16. Varicose Veins 17. Ulcer 18. Necrosis
outcomes:
Environmental enrichment for stroke and other non‐progressive brain injury
1. Multidimensional Health Locus Of Control Scale 2. Hospital Anxiety And Depression Scale 3. Rosenberg Self-esteem Scale 4. Depression Anxiety Scale
outcomes:
Renal denervation for resistant hypertension
1. Creatinine 2. Stroke 3. Congestive Heart Failure 4. Obstructive Sleep Apnea Of Adult 5. Glomerular Filtration Rate 6. Hypertensive Left Ventricular Hypertrophy 7. Insulin Resistance 8. Hospitalization 9. Adverse Event 10. Withdrawn From Research Study 11. Myocardial Infarction 12. All Cause Mortality 13. Kidney Finding 14. Blood Pressure Alteration 15. Quality of Life 16. Death 17. Blood glucose measurement 18. Measurement Of Serum Lipid Level 19. Atrial Fibrillation 20. Proteinuria
outcomes:
Interventions for altering blood pressure in people with acute subarachnoid haemorrhage
1. All Cause Mortality
outcomes:
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery
1. Functional Independence Training 2. Functional Independence Measure 3. Functionally Independent 4. Modified Rankin Scale 5. Death 6. Depression 7. Neurological Deficit 8. Seizure 9. Fracture 10. Barthel Index
outcomes:
Exercise‐based cardiac rehabilitation for coronary heart disease
1. Myocardial Infarction 2. Costs and Cost Analysis 3. Quality of Life 4. Death 5. Hospitalization 6. Coronary Revascularisation
outcomes:
Beta‐blockers in patients without heart failure after myocardial infarction
1. Myocardial Infarction 2. Angina Pectoris 3. Quality of Life 4. Cardiac Death 5. Death 6. Adverse Event
outcomes:
Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis
1. Myocardial Infarction 2. Stroke 3. Cardiovascular Mortality
outcomes:
Anticoagulants for acute ischaemic stroke
1. Death
outcomes:
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias
1. All Cause Mortality 2. Minor Bleed 3. Thromboembolic Event 4. Major Bleed
outcomes:
Local versus general anaesthesia for carotid endarterectomy
1. Stroke
outcomes:
Ultrasound guidance for arterial (other than femoral) catheterisation in adults
1. Treatment Success 2. Pseudoaneurysm
outcomes:
Treatment for telangiectasias and reticular veins
1. Hyperpigmentation Of Skin 2. Telangiectasis 3. Pain 4. Quality of Life 5. Clinical Resolution 6. Adverse Event 7. Clinical Improvement
outcomes:
Pharmacotherapy for hypertension‐induced left ventricular hypertrophy
1. All Cause Mortality 2. Serious Adverse Event 3. Cardiovascular Event 4. Heart Failure 5. Hospitalization 6. Withdrawal Due To Adverse Events 7. Adverse Event
outcomes:
Hybrid repair versus conventional open repair for aortic arch dissection
1. Dissection Procedure 2. Cardiovascular Injury 3. Renal ischaemia 4. Neurological Deficit 5. Respiratory finding
outcomes:
Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
1. Graft thrombosis 2. Complication 3. Duration Of Hospital Stay 4. Coronary Graft Patency
outcomes:
Stem cell therapy for dilated cardiomyopathy
1. All Cause Mortality 2. Procedural Related Injuries And Complications NEC 3. Adverse Event
outcomes:
Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration 
1. Aching Pain 2. Varicose Vein Finding 3. Quality of Life 4. Complication 5. Patient compliance 6. Itching
outcomes:
Cilostazol for intermittent claudication
1. Headache 2. Claudication 3. Artery revascularisation 4. Cardiovascular Event 5. Amputation 6. Quality of Life 7. Adverse Event 8. Calf Pain 9. Health-Related Quality of Life
outcomes:
Retroperitoneal versus transperitoneal approach for elective open abdominal aortic aneurysm repair
1. Abdominal Wall Hernia Procedure 2. Chronic Wound 3. Operation time 4. Hematoma 5. Death 6. Hospitalism 7. Intensive Care 8. Haemorrhage 9. Aortic cross-clamp time
outcomes:
Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke
1. All Cause Mortality 2. Venous recanalisation 3. Intracranial Hemorrhage 4. Functional ability
outcomes:
Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity
1. Hematoma 2. Injection Site Bruising 3. Pain Intensity
outcomes:
Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms
1. Cardiovascular Event 2. Aneurysm 3. Neurological Deficit 4. Respiratory finding
outcomes:
Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
1. All Cause Mortality 2. Heart Failure 3. Quality of Life 4. Hyperkalaemia 5. Cardiovascular Mortality 6. Hospitalization
outcomes:
Anticoagulation versus placebo for heart failure in sinus rhythm
1. Stroke 2. All Cause Mortality 3. Major Bleed
outcomes:
Vasodilators for primary Raynaud's phenomenon
1. Raynaud's Phenomenon 2. Short Form Health Survey - 36 3. Quality of Life 4. Raynaud Condition Score 5. Adverse Event 6. QuickDash 7. Health Assessment Questionnaire
outcomes:
Fludrocortisone for orthostatic hypotension
1. Falls 2. Dizziness On Standing Up 3. Presyncope 4. Serious Adverse Event 5. Quality of Life 6. Lightheadedness 7. Adverse Event 8. Postural Drop In Blood Pressure
outcomes:
Exercise‐based cardiac rehabilitation for adults after heart valve surgery
1. Costs and Cost Analysis 2. Exercise Test Finding 3. Quality of Life 4. Left Ventricular Ejection Fraction 5. Death 6. General Body State Finding 7. Adverse Event 8. Return to Work
outcomes:
Endoluminal interventions versus surgical interventions for stenosis in vein grafts following infrainguinal bypass
1. All Cause Mortality 2. Primary Patency
outcomes:
Thrombolytic therapy for pulmonary embolism
1. All Cause Mortality 2. Recurrent Pulmonary Embolism 3. Hemorrhage
outcomes:
Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults
1. Blood pressure measurement 2. Heart Rate 3. Systolic Blood Pressure 4. Urinalysis 5. Diastolic Blood Pressure 6. Cardiovascular disease 7. Low Density Lipoprotein Cholesterol Measurement 8. Adverse Event 9. Patient Satisfaction
outcomes:
Antibiotics for secondary prevention of coronary heart disease
1. Myocardial Infarction 2. Stroke 3. Quality of Life 4. Sudden Cardiac Death 5. Death 6. Adverse Event
outcomes:
Surgical and radiological interventions for treating symptomatic extracranial cervical artery dissection
1. Disability 2. Ipsilateral stroke
outcomes:
Long‐term effects of weight‐reducing drugs in people with hypertension
1. Withdrawn From Research Study 2. All Cause Mortality 3. Adverse Drug Reaction 4. Weight change 5. Blood Pressure Alteration 6. Adverse Event 7. Cardiovascular Morbidity
outcomes:
Blood pressure targets in adults with hypertension
1. All Cause Mortality 2. Serious Adverse Event 3. Cardiovascular observations 4. Death 5. Cardiovascular Mortality
outcomes:
Trypanocidal drugs for late‐stage, symptomatic Chagas disease (Trypanosoma cruzi infection)
1. Finding Of Blood Group Antibody Titer 2. Parasitemia
outcomes:
Angioplasty versus stenting for iliac artery lesions
1. Maxillofacial Technical Procedure 2. Clinical Improvement